Stay updated with breaking news from John Torous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NPR's Leila Fadel speaks with Dr. John Torous, director of digital psychiatry at Beth Israel Deaconess Medical Center in Boston, about the first app being approved to help treat depression.
The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.
(CNN) — The US Food and Drug Administration is allowing the use of Rejoyn, the first prescription digital treatment for major depressive disorder.Rejoyn, made by<a class="excerpt-read-more" href="https://wsvn.com/news/us-world/fda-clears-first-digital-treatment-for-depression-but-experts-caution-that-research-is-still-early/">Read More</a>
Rejoyn is an app intended for use alongside antidepressant medications for people with major depressive disorder.
It is “designed to act like physical therapy for the brain,” a scientific advisor says.